Last updated 2026-06-18
Total raised
—
Stage
Pre-Funding
Founded
2017
Headcount
6
HQ
, Israel
Sector
Health Tech & Life Sciences
About
BARcure provides a therapeutic platform applicable to various B-cell neoplasms, primarily non-Hodgkins lymphoma (NHL). The company is currently focusing on the development of two BAR-based products for the treatment of DLBCL and MCL. BARcure specifically targets malignant B cells with novel immunotherapies designed to kill tumor cells while sparing normal B cells. The company leverages the robust research work done by Prof. Michael Pfreundschuh from Saarland University in Germany.
Q&A
- What is BARcure's primary focus in terms of therapeutic development?
- BARcure is focused on developing two BAR-based products for the treatment of Diffuse Large B-cell Lymphoma (DLBCL) and Mantle Cell Lymphoma (MCL), which are types of B-cell neoplasms.
- What is BARcure's current operational status?
- BARcure is currently inactive, having ceased operations in April 2019.
- When was BARcure founded?
- BARcure was founded in June 2017.
- How many employees did BARcure have?
- BARcure had an employee count in the 1-10 range.
- What is BARcure's primary sector classification?
- BARcure's primary sector is Health Tech & Life Sciences.
- What is BARcure's current funding stage?
- BARcure is in the Pre-Funding stage.
- Where is BARcure's headquarters located?
- BARcure's headquarters is located in Ness Ziyyona, Israel.
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug Delivery
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Tags
biopharmaceuticalimmunologytherapeuticsdrug-deliverycancerpharmaceuticalsimmuno-theraphyoncologyimmunotherapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | barcure.co.il/ |
|---|
Identifiers & details
| Founded | 2017-6 |
|---|---|
| Employees (exact) | 6 |
| Status reason | Non Active, Apr 2019 ceased to operate |